Inseok Park

Inseok Park

Auto-generated profile, based on publicly available information

Inseok Park

Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2016 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
CPChansub Park
Chansub Park
KPKyeongmee Park
Kyeongmee Park
JKJiyoung Kim
Jiyoung Kim
YSYoungjoo Sin
Youngjoo Sin
IPInseok Park
Inseok Park
GGGeumhee Gwak
Geumhee Gwak
The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressive clinical features. We investigated the clinical implications of single hormone receptor negativity in a luminal B HER2-negative group. We collected luminal B HER2-negative breast cancer data that were estrogen receptor (ER) and/or progesterone receptor (PR) positive, Ki 67 high (>14 %), and HER2 negative and divided them into the ER- and PR-positive group and the ER- or PR-negative group. We analyzed the clinical and pathological data and survival according to ER or PR loss. There were no statistical differences in TNM stage, breast and axillary operative methods, or number of tumors between the ER- and PR-positive group and ER- or PR-negative group. However, the ER- or PR-negative group was associated with older age (≥45 years), higher histological grade, lower Bcl-2 expression, and far higher Ki 67 (>50 %). Disease-free survival (DFS) and overall survival (OS) were shorter in the ER- or PR-negative group than that in the ER- and PR-positive group (p = 0.0038, p = 0.0071). ER- or PR-negative subgroup showed worse prognosis than ER- and PR-positive subgroup in the luminal B HER2-negative group. We could consider the negativity of ER or PR as prognostic marker in luminal B HER2-negative subtype of breast cancer.

31 August 2020 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
YCYoungjae CHO
Youngjae CHO
IPIn Seok Park
In Seok Park
JKJungbin Kim
Jungbin Kim
HCHyun Jin Cho
Hyun Jin Cho
GGGeum Hee Gwak
Geum Hee Gwak
KKKi Hwan Kim
Ki Hwan Kim
Purpose: Small bowel obstruction (SBO) is a common disease that requires hospitalization. The most common cause of SBO is postoperative adhesion. Delayed timing of operations in patients who need surgical intervention results in mortality or morbidity. A number of studies on SBO have established criteria for emergency surgery. However, few objective clinical parameters are available for screening patients who need a delayed operation. Therefore, we analyzed factors that affect the clinical course of SBO to select appropriate therapeutic plans for reducing the risk of complications in these patients.Methods: We investigated the clinical characteristics of patients admitted to the surgery department of our hospital between January 1, 2015, and December 31, 2016, who were diagnosed with SBO. Patients were divided into an operative treatment group (n = 12) and a conservative treatment group (n = 96). We compared clinical characteristics between the 2 groups.Results: The operative treatment group underwent more operations before SBO than the conservative treatment group (P = 0.007). Initial leukocyte counts (P = 0.004) and C-reactive protein (CRP) levels (P = 0.028) were elevated in the operative group. Body mass index (BMI) was lower in the operative group (P = 0.013).Conclusion: The number of operations before SBO, leukocyte counts, CRP levels, and BMI were useful parameters for selecting patients who needed an urgent operation for SBO.

15 March 2020 in Journal of Minimally Invasive Surgery
Verified
Journal Article
Open access
PDF file
BKBomi Kim
Bomi Kim
JKJungbin Kim
Jungbin Kim
IPInseok Park
Inseok Park
HCHyunjin Cho
Hyunjin Cho
GGGeumhee Gwak
Geumhee Gwak
KKKihwan Kim
Kihwan Kim
Bomi Kim, M.D., Jungbin Kim, M.D., Inseok Park, M.D., Hyunjin Cho, M.D., Geumhee Gwak, Ph.D., Keun Ho Yang, Ph.D., Byung-Noe Bae, Ph.D., Kihwan Kim, Ph.D.. Journal of Minimally Invasive Surgery 2020;23:43-8. https://doi.org/10.7602/jmis.2020.23.1.43

1 January 2020 in Asian Journal of Surgery
Verified
Journal Article
Open access
JKJungbin Kim
Jungbin Kim
HCHyunjin Cho
Hyunjin Cho
GGGeumhee Gwak
Geumhee Gwak
KYKeunho Yang
Keunho Yang
JKJi-Young Kim
Ji-Young Kim
IPInseok Park
Inseok Park
Axillary lymph node staging (ALNS) is an important step in the treatment of breast cancer and sentinel lymph node biopsy (SLNB) is a standard procedure for ALNS. Recently, the use of positron emission tomography/computed tomography (PET/CT) for whole body staging in patients with breast cancer has been increasing. The negative predictive value (NPV) of the specific diagnostic modality is the crucial value for excluding axillary lymph node metastasis (ALNM) and guiding the decision not to proceed with axillary lymph node dissection. The aim of this study was to identify patient groups in which PET/CT yields a high NPV for ALNS. We reviewed data from the records of 262 patients with breast cancer who underwent PET/CT before surgery between February 2009 and March 2018. We searched for factors associated with pathological axillary lymph node metastasis in patients with negative ALNM on PET/CT. Then, we calculated the NPV of PET/CT for ALNS in the patient group without the identified factors and in all patients. Age ≥75 years and tumor size on ultrasonography (US) ≥ 15 mm were the associated factors; the NPV of PET/CT in patients without these factors compared to all patients was 97.2% versus 88.7%. The NPV of PET/CT for ALNS in patients younger than 75 years and with tumor size on US < 15 mm is higher than that in all patients and comparable to the NPV of SLNB reported in previous studies (90.1-97.0%).